Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 802–803 | Cite as

The Prognostic Significance of Resection Margins After Pancreaticoduodenectomy

  • Stijn van Roessel
  • Jennifer F. TsengEmail author
ASO Author Reflections



J.F. Tseng is a board member of Mauna Kea Technologies and received a stipend and equity.


  1. 1.
    Washington K, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with carcinoma of the pancreas, 2016. Retrieved 25 May 2017 at
  2. 2.
    Campbell F, Cairns A, Duthie F, Feakins R. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct, 2017. Retrieved Sept 2018 at
  3. 3.
    van Roessel S, Kasumova GG, Tabatabaie O, et al. Pathological margin clearance and survival after pancreaticoduodenectomy in a US and European pancreatic center. Ann Surg Oncol. 2018;25:1760–7.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? Ann Surg. 2013;257:731–6.CrossRefGoogle Scholar
  5. 5.
    Strobel O, Hank T, Hinz U, et al. Pancreatic cancer surgery: the new R-status counts. Ann Surg. 2017;265:565–73.CrossRefGoogle Scholar
  6. 6.
    Verbeke C, Lohr M, Karlsson JS, Del Chiaro M. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Cancer Treat Rev. 2015;41:17–26.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Surgery, Cancer Center AmsterdamAmsterdam UMC, University of AmsterdamAmsterdamThe Netherlands
  2. 2.Department of Surgery, Boston Medical CenterBoston UniversityBostonUSA

Personalised recommendations